Researchers seeking participants
Patients required for a multiple sclerosis clinical trial
April 2010
ATX-MS-1467 is a new drug under development by Apitope Technology (Bristol) Ltd as a potential new treatment for patients with relapsing multiple sclerosis.
We are currently seeking 18-55 year old male and female patients with relapsing multiple sclerosis (RMS) to join in the trial currently underway in the UK.